BRPI0911679A2 - composto aciltiouréia, ou sal do mesmo, e seu uso - Google Patents

composto aciltiouréia, ou sal do mesmo, e seu uso

Info

Publication number
BRPI0911679A2
BRPI0911679A2 BRPI0911679A BRPI0911679A BRPI0911679A2 BR PI0911679 A2 BRPI0911679 A2 BR PI0911679A2 BR PI0911679 A BRPI0911679 A BR PI0911679A BR PI0911679 A BRPI0911679 A BR PI0911679A BR PI0911679 A2 BRPI0911679 A2 BR PI0911679A2
Authority
BR
Brazil
Prior art keywords
salt
acylthiourea compound
acylthiourea
compound
Prior art date
Application number
BRPI0911679A
Other languages
English (en)
Inventor
Hidenori Fujita
Kosuke Egami
Yoshimitsu Suda
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of BRPI0911679A2 publication Critical patent/BRPI0911679A2/pt
Publication of BRPI0911679B1 publication Critical patent/BRPI0911679B1/pt
Publication of BRPI0911679B8 publication Critical patent/BRPI0911679B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
BRPI0911679A 2008-04-10 2009-04-09 composto aciltioureia ou um sal do mesmo, uso do dito composto para tratar câncer, bem como agente farmacêutico, agente antitumoral e composição farmacêutica compreendendo dito composto BRPI0911679B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008-102832 2008-04-10
JP2008102832 2008-04-10
PCT/JP2009/001655 WO2009125597A1 (ja) 2008-04-10 2009-04-09 アシルチオウレア化合物又はその塩、及びその用途

Publications (3)

Publication Number Publication Date
BRPI0911679A2 true BRPI0911679A2 (pt) 2015-10-13
BRPI0911679B1 BRPI0911679B1 (pt) 2020-09-29
BRPI0911679B8 BRPI0911679B8 (pt) 2021-05-25

Family

ID=41161733

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911679A BRPI0911679B8 (pt) 2008-04-10 2009-04-09 composto aciltioureia ou um sal do mesmo, uso do dito composto para tratar câncer, bem como agente farmacêutico, agente antitumoral e composição farmacêutica compreendendo dito composto

Country Status (19)

Country Link
US (1) US8304427B2 (pt)
EP (1) EP2287155B1 (pt)
JP (1) JP4667537B2 (pt)
KR (1) KR101414931B1 (pt)
CN (1) CN101998951B (pt)
AU (1) AU2009234978B2 (pt)
BR (1) BRPI0911679B8 (pt)
CA (1) CA2720552C (pt)
CY (1) CY1114166T1 (pt)
DK (1) DK2287155T3 (pt)
ES (1) ES2423851T3 (pt)
HR (1) HRP20130984T1 (pt)
MX (1) MX2010011097A (pt)
PL (1) PL2287155T3 (pt)
PT (1) PT2287155E (pt)
RU (1) RU2503664C2 (pt)
SI (1) SI2287155T1 (pt)
TW (1) TWI438193B (pt)
WO (1) WO2009125597A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314253B2 (en) 2008-07-01 2016-04-19 Amendia, Inc. Tissue modification devices and methods
ES2599458T3 (es) 2008-10-14 2017-02-01 Sunshine Lake Pharma Co., Ltd. Compuestos y métodos de uso
EP2408300B1 (en) 2009-03-21 2016-05-11 Sunshine Lake Pharma Co., Ltd. Amino ester derivatives, salts thereof and methods of use
US20130225581A1 (en) 2010-07-16 2013-08-29 Kyowa Hakko Kirin Co., Ltd Nitrogen-containing aromatic heterocyclic derivative
WO2012121273A1 (ja) * 2011-03-07 2012-09-13 味の素株式会社 塩味増強剤
TWI594986B (zh) * 2011-12-28 2017-08-11 Taiho Pharmaceutical Co Ltd Antineoplastic agent effect enhancer
WO2013111798A1 (ja) 2012-01-27 2013-08-01 国立大学法人 富山大学 セリンラセマーゼ阻害剤
US9149471B2 (en) * 2013-09-30 2015-10-06 National University Corporation Tokyo University Of Agriculture And Technology Therapeutic agent for osteoporosis
WO2016161952A1 (zh) * 2015-04-07 2016-10-13 广东众生药业股份有限公司 酪氨酸激酶抑制剂及包含该酪氨酸激酶抑制剂的药物组合物
PT3290405T (pt) * 2015-04-30 2021-03-23 Taiho Pharmaceutical Co Ltd Sal de ácido mesílico de composto de aciltioureia, cristal do mesmo, e respetivos processos de produção
SG10201912684TA (en) * 2015-06-25 2020-03-30 Taiho Pharmaceutical Co Ltd Therapeutic agent for fibrosis
CN105601566A (zh) * 2016-02-02 2016-05-25 张敏 一种护理烧伤后感染的药物组合物
WO2018028591A1 (zh) * 2016-08-09 2018-02-15 殷建明 一种喹啉衍生物及其用途
WO2018151177A1 (ja) 2017-02-15 2018-08-23 大鵬薬品工業株式会社 医薬組成物
JP7074760B2 (ja) * 2017-09-08 2022-05-24 大鵬薬品工業株式会社 抗腫瘍剤及び抗腫瘍効果増強剤
KR20210060465A (ko) 2018-09-18 2021-05-26 다이호야쿠힌고교 가부시키가이샤 아실티오우레아 화합물과 아비라테론의 병용 요법
TWI872203B (zh) * 2020-02-14 2025-02-11 日商大鵬藥品工業股份有限公司 醯基硫脲化合物的製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds
AU2223201A (en) 1999-12-24 2001-07-09 Kirin Beer Kabushiki Kaisha Quinoline and quinazoline derivatives and drugs containing the same
AU9598601A (en) * 2000-10-20 2002-04-29 Eisai Co Ltd Nitrogenous aromatic ring compounds
AU2002313249B2 (en) 2001-06-22 2008-08-21 Kirin Pharma Kabushiki Kaisha Quinoline derivative and quinazoline derivate inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
US6858637B2 (en) 2002-03-28 2005-02-22 Neurogen Corporation Substituted biaryl amides as C5a receptor modulators
EP2210607B1 (en) 2003-09-26 2011-08-17 Exelixis Inc. N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
WO2005080377A1 (ja) 2004-02-20 2005-09-01 Kirin Beer Kabushiki Kaisha TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
US7531532B2 (en) 2004-02-27 2009-05-12 Eisai R&D Management Co., Ltd. Pyridine derivative and pyrimidine derivative
WO2005121125A1 (en) 2004-06-09 2005-12-22 Pfizer Inc. Ether-linked heteroaryl compounds
AU2006229343A1 (en) 2005-03-28 2006-10-05 Kirin Pharma Kabushiki Kaisha Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency
EP1874759A4 (en) * 2005-04-06 2009-07-15 Exelixis Inc C-MET MODULATORS MODULATORS AND METHODS OF USE

Also Published As

Publication number Publication date
AU2009234978A1 (en) 2009-10-15
KR20100132023A (ko) 2010-12-16
TWI438193B (zh) 2014-05-21
CA2720552C (en) 2016-06-14
HK1151288A1 (en) 2012-01-27
DK2287155T3 (da) 2013-07-29
HRP20130984T1 (hr) 2013-11-22
JP4667537B2 (ja) 2011-04-13
AU2009234978B2 (en) 2014-03-06
SI2287155T1 (sl) 2013-10-30
MX2010011097A (es) 2010-11-01
BRPI0911679B1 (pt) 2020-09-29
PT2287155E (pt) 2013-07-26
CN101998951A (zh) 2011-03-30
EP2287155A1 (en) 2011-02-23
CA2720552A1 (en) 2009-10-15
EP2287155B1 (en) 2013-07-17
TW201000451A (en) 2010-01-01
KR101414931B1 (ko) 2014-07-04
RU2010145526A (ru) 2012-05-20
WO2009125597A1 (ja) 2009-10-15
PL2287155T3 (pl) 2013-12-31
JPWO2009125597A1 (ja) 2011-08-04
RU2503664C2 (ru) 2014-01-10
BRPI0911679B8 (pt) 2021-05-25
CN101998951B (zh) 2013-07-17
CY1114166T1 (el) 2016-08-31
US20110034439A1 (en) 2011-02-10
US8304427B2 (en) 2012-11-06
ES2423851T3 (es) 2013-09-24
EP2287155A4 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
BRPI0911679A2 (pt) composto aciltiouréia, ou sal do mesmo, e seu uso
BRPI1013999A2 (pt) composto de azabiciclo e seu sal.
BR112012002349A2 (pt) composto,e, uso do mesmo
BRPI0808098A2 (pt) 4-aril-1,4-di-hidro-1,6-naftiridinamidas substituídas e seu uso
BRPI1008740A2 (pt) Proteínas pesticidas e métodos para seu uso.
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI1011521A2 (pt) Composto de hidrazida e uso do mesmo no controle de pragas.
BRPI0818201A2 (pt) Composto de azolcarboxamida ou sal do mesmo
BRPI0914536A2 (pt) tiadiazoliloxifenilamidinas e o uso destas como fungicidas
BRPI0817626A2 (pt) Ácidos 2-substituído-6-amino-5-alquil, alquenil ou alquinil-4-pirimidinacarboxílicos e ácidos 6-substituído-4-amino-3-alquil, alquenil ou aquinil picolínicos e seu uso como herbicidas
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0913885A2 (pt) Tiadiazoliloxifenilamidinas e seus uso como fungicidas
BRPI0815349A2 (pt) 6-amino-5-cloro-4-pirimidinacarboxilatos substituídos com 2-(2-fluorofeni-la) e seu uso como herbicidas
BRPI0920648A2 (pt) Combinações pesticidas contendo sulfoxaflor
DK2331687T3 (da) Antimikrobielle midler
BRPI0810654A2 (pt) Tiadiazoliloxifenilamidinas e o seu uso como fungicidas.
BRPI0906478A2 (pt) anticorpo anti-nr10 e uso do mesmo
BR112014014769A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou sal.
BRPI1007494A2 (pt) composto e uso do mesmo
BRPI1014369A2 (pt) sal de abt-263 e suas formas em estado sólido
BRPI0907365A2 (pt) Composição antimicrobiana e uso
DK2108260T3 (da) Sammensætning med biocid aktivitet til vandige præparater
BRPI0807004A2 (pt) Sal
BRPI0907254A2 (pt) Combinação biocida para uso em aplicações agrícolas
BRPI0808798A2 (pt) Fenoxifenilamidinas 3,5-dissubstituídas e seu uso como fungicidas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF